Tagged with Vision 2030

Dimitri Livadas – CEO Pharma, Saudi Chemical Company Holding
Ismail Shehada – CEO, Tabuk Pharmaceuticals
Saudi Arabia’s Vision 2030 Healthcare Transformation Explained
Ahmed Aljedai – Assistant Deputy Minister of Therapeutic Affairs for Support Services, Ministry of Health, Saudi Arabia
Three Key Trends to Watch in Saudi Arabia’s Pharma Industry
Fayad Al Dandashi – CEO, Tamer HealthCare
Ayman Tamer – Chairman & Managing Partner, Tamer Group
Vision 2030: An Overview
Interview: Daniel de Labauve d’Arifat – CEO, PNL (Pharmacie Nouvelle Limited), Mauritius
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here